Depleted uranium (DU) is commonly used in military armor and munitions, and thus, exposure of
soldiers and non-combatants is potentially frequent and widespread. DU is considered a suspected human
carcinogen, affecting the bronchial cells of the lung. However, few investigations have studied DU in
human bronchial cells. Accordingly, we determined the cytotoxicity and clastogenicity of both particulate
(water-insoluble) and soluble DU in human bronchial fibroblasts (WTHBF-6 cells). We used uranium
trioxide (UO3) and uranyl acetate (UA) as prototypical particulate and soluble DU salts, respectively.
After a 24 h exposure, both UO3 and UA induced concentration-dependent cytotoxicity in WTHBF-6
cells. Specifically, 0.1, 0.5, 1, and 5 μg/cm2 UO3 induced 99, 57, 32, and 1% relative survival, respectively.
Similarly, 100, 200, 400, and 800 μM UA induced 98, 92, 70, and 56% relative survival, respectively.
When treated with chronic exposure, up to 72 h, of either UO3 or UA, there was an increased degree of
cytotoxicity. We assessed the clastogenicity of these compounds and found that at concentrations of 0,
0.5, 1, and 5 μg/cm2 UO3, 5, 6, 10, and 15% of metaphase cells exhibit some form of chromosome
damage. UA did not induce chromosome damage above background levels. There were slight increases
in chromosome damage induced when we extended the UO3 treatment time to 48 or 72 h, but no
meaningful increase in chromosome damage was observed with chronic exposure to UA.